Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$88,669,912
-$4,691,864 QoQ
Shares Held
467,619
-1.2% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#131
of 1,467 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $1,983,048,474 across 16 Drug Manufacturers - General names. AZN ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
559,339 | $670,888,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,137,643 | $288,927,190 | |
| 3 | ABBV |
AbbVie Inc.
|
980,805 | $246,809,766 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,848,360 | $237,514,257 | |
| 5 | AMGN |
Amgen Inc
|
636,122 | $230,352,496 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
467,619 | $88,669,912 | |
| 7 | NVO |
Novo Nordisk A S
|
1,566,451 | $75,095,658 | |
| 8 | PFE |
Pfizer Inc
|
1,993,256 | $47,997,600 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,669,912 | 467,619 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $93,361,776 | 473,389 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||